These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38622482)

  • 1. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.
    Minareci Y; Ak N; Sozen H; Tosun OA; Kucukgergin C; Aydin F; Bingul İ; Salihoglu MY; Topuz S
    Mol Biol Rep; 2024 Apr; 51(1):515. PubMed ID: 38622482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-92 expression in patients with ovarian epithelial carcinoma.
    Guo F; Tian J; Lin Y; Jin Y; Wang L; Cui M
    J Int Med Res; 2013 Oct; 41(5):1456-61. PubMed ID: 23963852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer.
    Zhang B; Li Y; Li Y; Zhao H; An R
    Dis Markers; 2022; 2022():2751696. PubMed ID: 35371343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer.
    Zuberi M; Khan I; Mir R; Gandhi G; Ray PC; Saxena A
    PLoS One; 2016; 11(4):e0153902. PubMed ID: 27092777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-21 and Mir-125b as theranostic biomarkers for epithelial ovarian cancer in Tunisian women.
    Habel A; Nassar F; Itani M; Bouaziz H; Hadj-Ahmed M; Msheik Z; Stayoussef M; Nasr R; Yacoubi-Loueslati B
    Afr Health Sci; 2023 Jun; 23(2):256-264. PubMed ID: 38223583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M; Yang Z; Ye W; Xu H; Hua X
    PLoS One; 2014; 9(8):e103965. PubMed ID: 25090005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of microRNA-34a, let-7f and microRNA-31 in epithelial ovarian cancer prediction.
    Kumar V; Gupta S; Varma K; Chaurasia A; Sachan M
    J Gynecol Oncol; 2022 Jul; 33(4):e49. PubMed ID: 35557032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA Expression Profiling of Epithelial Ovarian Cancer Identifies New Markers of Tumor Subtype.
    Rattanapan Y; Korkiatsakul V; Kongruang A; Siriboonpiputtana T; Rerkamnuaychoke B; Chareonsirisuthigul T
    Microrna; 2020; 9(4):289-294. PubMed ID: 32703147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c.
    Liu S; Yuan L; Li J; Liu Y; Wang H; Ren X
    Ann Med; 2023 Dec; 55(1):908-919. PubMed ID: 36896567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.
    Hong F; Li Y; Xu Y; Zhu L
    J Int Med Res; 2013 Feb; 41(1):64-71. PubMed ID: 23569131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Cell-Free miR-373, miR-200a, miR-200b and miR-200c in Patients with Epithelial Ovarian Cancer.
    Meng X; Müller V; Milde-Langosch K; Trillsch F; Pantel K; Schwarzenbach H
    Adv Exp Med Biol; 2016; 924():3-8. PubMed ID: 27753009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum microRNA-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer.
    Xu YZ; Xi QH; Ge WL; Zhang XQ
    Asian Pac J Cancer Prev; 2013; 14(2):1057-60. PubMed ID: 23621186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of microRNA-196b Accelerates Invasiveness of Cancer Cells in Recurrent Epithelial Ovarian Cancer Through Regulation of Homeobox A9.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
    Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.
    Cao Q; Lu K; Dai S; Hu Y; Fan W
    Int J Clin Exp Pathol; 2014; 7(5):2392-401. PubMed ID: 24966949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer.
    Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P
    Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of microRNA-203 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.
    Wang S; Zhao X; Wang J; Wen Y; Zhang L; Wang D; Chen H; Chen Q; Xiang W
    Med Oncol; 2013; 30(3):681. PubMed ID: 23918241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential MicroRNA Expression Profiles in Primary and Recurrent Epithelial Ovarian Cancer.
    Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Lee YS; Cho YL
    Anticancer Res; 2015 May; 35(5):2611-7. PubMed ID: 25964536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.